CT
GILD icon

Chicago Trust’s Gilead Sciences GILD Stock Holding History

Chicago Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
9,103
-1,848
-17% -$243K 0.17% 122
2026
Q1 		$1.53M Buy
10,951
+1,488
+16% +$208K 0.24% 88
2025
Q4 		$1.16M Buy
9,463
+3,809
+67% +$463K 0.18% 101
2025
Q3 		$628K Buy
5,654
+2,754
+95% +$313K 0.09% 205
2025
Q2 		$322K Buy
2,900
+597
+26% +$63.5K 0.05% 318
2025
Q1 		$258K Buy
+2,303
New +$238K 0.05% 312

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Chicago Trust's GILD Position: Q2 2026 in Review

Chicago Trust reduced its Gilead Sciences (GILD) stake by 17% in Q2 2026, selling an estimated $243K and leaving 9,103 shares worth $1.15M. The position accounts for 0.17% of the portfolio, ranked #122.

Chicago Trust first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.53M in Q1 2026. 485 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Chicago Trust held 9,103 shares of Gilead Sciences worth $1.15M as of Q2 2026.
  • Chicago Trust sold 1,848 Gilead Sciences shares in Q2 2026, an estimated $243K.
  • Gilead Sciences made up 0.17% of Chicago Trust's portfolio in Q2 2026, its #122 holding.
  • Chicago Trust first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Chicago Trust's Gilead Sciences position peaked at $1.53M in Q1 2026.
  • 485 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.